Breast Implant Illness May Be Rooted in Mast Cell Activation: A Case-Controlled Retrospective Analysis.

Autor: Nagy ÈS; From the Sydney Oncoplastic Surgery, North Shore Health Hub, St Leonards, NSW, Australia., Westaway M; Coronation Medical, Milton, QLD, Australia., Danieletto S; Douglas Hanly Moir, Macquarie University Hospital, Macquarie Park, NSW, Australia., Afrin LB; AIM Center for Personalized Medicine, Purchase, NY.

Publikováno v: Annals of surgery open : perspectives of surgical history, education, and clinical approaches [Ann Surg Open] 2024 Mar 13; Vol. 5 (1), pp. e398. Date of Electronic Publication: 2024 Mar 13 (Print Publication: 2024).

Revolutionizing CAR T-Cell Therapies: Innovations in Genetic Engineering and Manufacturing to Enhance Efficacy and Accessibility.

Autor: Giorgioni, Lorenzo¹ (AUTHOR) lorenzo.giorgioni@uniroma1.it, Ambrosone, Alessandra² (AUTHOR) alessandra.ambrosone@guest.iss.it, Cometa, Maria Francesca² (AUTHOR) mariafrancesca.cometa@iss.it, Salvati, Anna Laura³ (AUTHOR) robert.nistico@gmail.com, Nisticò, Robert^3,4 (AUTHOR), Magrelli, Armando² (AUTHOR) armando.magrelli@iss.it

Publikováno v: International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 19, p10365. 22p.

Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancer.

Autor: Tan AC; SAN Integrated Cancer Centre, Sydney Adventist Hospital, Wahroonga, Australia., Li BT; Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY, USA.; Sydney Medical School, University of Sydney, Sydney, NSW, Australia., Nahar K; SAN Integrated Cancer Centre, Sydney Adventist Hospital, Wahroonga, Australia., Danieletto S; SAN Integrated Cancer Centre, Sydney Adventist Hospital, Wahroonga, Australia., Fong ES; SAN Integrated Cancer Centre, Sydney Adventist Hospital, Wahroonga, Australia., Currer T; SAN Integrated Cancer Centre, Sydney Adventist Hospital, Wahroonga, Australia., Parasyn A; SAN Integrated Cancer Centre, Sydney Adventist Hospital, Wahroonga, Australia., Middleton P; SAN Integrated Cancer Centre, Sydney Adventist Hospital, Wahroonga, Australia., Wong H; SAN Integrated Cancer Centre, Sydney Adventist Hospital, Wahroonga, Australia., Smart D; SAN Integrated Cancer Centre, Sydney Adventist Hospital, Wahroonga, Australia., Rutovitz JJ; SAN Integrated Cancer Centre, Sydney Adventist Hospital, Wahroonga, Australia., McCloud P; McCloud Consulting Group, Australia., Hughes TM; SAN Integrated Cancer Centre, Sydney Adventist Hospital, Wahroonga, Australia.; Sydney Medical School, University of Sydney, Sydney, NSW, Australia., Marx GM; SAN Integrated Cancer Centre, Sydney Adventist Hospital, Wahroonga, Australia.; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.

Publikováno v: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2018 Apr; Vol. 14 (2), pp. e161-e166. Date of Electronic Publication: 2017 Sep 29.

Engineered CAR‐T cells targeting the non‐functional P2X purinoceptor 7 (P2X7) receptor as a novel treatment for ovarian cancer.

Autor: Bandara, Veronika¹ (AUTHOR), Niktaras, Victoria M² (AUTHOR), Willett, Vasiliki J² (AUTHOR), Chapman, Hayley² (AUTHOR), Lokman, Noor A² (AUTHOR), Macpherson, Anne M² (AUTHOR), Napoli, Silvana¹ (AUTHOR), Gundsambuu, Batjargal¹ (AUTHOR), Foeng, Jade³ (AUTHOR), Sadlon, Timothy J¹ (AUTHOR), Coombs, Justin⁴ (AUTHOR), McColl, Shaun R^3,4 (AUTHOR), Barry, Simon C¹ (AUTHOR), Oehler, Martin K^2,5 (AUTHOR), Ricciardelli, Carmela² (AUTHOR) carmela.ricciardelli@adelaide.edu.au

Publikováno v: Clinical & Translational Immunology. 2024, Vol. 13 Issue 5, p1-17. 17p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.